Gubra | Sustainability Performance
Gubra A/S is involved in biotech research, focusing on drug discovery and development primarily related to obesity and metabolic diseases, with an emphasis on innovative therapeutic approaches.
2008
Denmark
201 - 500 employees
Biotechnology
$100M - 500M in revenue
$100M - 500M in profitability
Sustainability Ranking & Industry Benchmark
#5035
Overall#104
in Denmark#73
in BiotechnologySustainability Maturity
Sustainability Intent
Overview
Environmental
Carbon certificatesDigital emissionsEnergy consumptionGovernance
TargetsESG scores and ExclusionsFinancial Data
Business performanceCapital & innovationAnalyst projections
Renewable energy
Aligned
Market cap
Revenue
R&D intensity
Renewable electricity
Reveal data for 1 credit
100%2022
Industry rank: 5 out of 251
Total electricity consumption
and % renewables
(MWh, % of consumption)
Industry rank: 5 out of 251
Total electricity
Share of renewable electricity
Industry benchmark
Digital Emissions
CO2e per visit (g)
Industry benchmark
B/M 0.26 g
Green HostingYes
Controversy level
- Gubra's preclinical drug discovery services involve animal testing in obesity and metabolic disease research.
Carbon certificate projects
Reveal data for 3 credits
| Subsector | Country | Transaction date ⓘ | |||||
|---|---|---|---|---|---|---|---|
| 2019 | 2020 | 2021 | 2022 | 2023 | Total | ||
| ******* | ******* | - | ******* | - | - | - | ******* |
| ******* | ******* | - | - | - | - | ******* | ******* |
Powered by AlliedOffsets and illuminem
Market cap
Revenue
EBITDA
Operating margin
Revenue & EBITDA
$398.4MFY2025 revenue
Total Annual
Revenue & EBITDA
($ B)
Annual revenue
EBITDA
3 year change
Margin trends
Margin as % of revenue
Gross margin
Operating margin
Net margin
Powered by illuminem
Free cashflow
Capex
Debt/equity ratio
R&D intensity
8.8%FY2025
R&D as % of revenue
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Return on invested capital
145.0%FY2026
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Analyst revenue estimates & actuals
Analyst consensus vs actuals
($ B)
Actual revenue
Consensus estimates
Estimate only
0.0
20230.0
20240.4
▲ 0.1%
2.0
2030Powered by illuminem
Environmental policy coverage
Carbon reduction policy
Not available
Human rights policy
Not available
Recycling policy
Not available
Workplace health & safety policy
Not available
56%
Independent Directors
5 out of 9 incl. management
Overall score
0
Environment
0
Social
0
Governance
0
Exclusion screening
Adult content
Not available
Alcoholic
Not available
Animal testing
Not available
Firearms
Not available
Tobacco
Not available
Gambling
Not available
Nuclear
Not available
